Dr. Mithu Maheswaranathan on How Metformin Benefits Patients With Lupus

Metformin, which has typically been used to treat type 2 diabetes mellitus, has been explored for its anti-inflammatory potential in patients with systemic lupus erythematosus (SLE). Rheumatologist and lupus expert Dr. Mithu Maheswaranathan spoke to DocWire News about a recent study which shows that metformin is a promising complementary therapy for SLE, and how the results can better inform care in rheumatology.